Top Tweets for #RadioEmbolization
Assessment of Y-90 Radioembolization Treatment Response for Hepatocellular Carcinoma Cases Using MRI Radiomics
You can see the free full text of the research by Mennaallah Mahmoud et al.
Link : https://t.co/csKWGWPznK
#radiomics #Y90 #radioembolization
Dr. Garrett Green, a Radiation Oncologist will share his perspective on Challenges Remaining for Y90 during the Radioembolization summit. Join us this Saturday (8/1/26) for this virtual summit.
Register here: https://t.co/E7fyBQVYXz
#embolization #radioembolization #Y90 #interventionalradiology #interventionaloncology
⭐ Editor's Pick
☢️ Is Radioembolization Reshaping HCC Treatment?
Explore the latest evidence on radioembolization, from expanding indications to evolving clinical applications in HCC.
🔓 Open Access
📖 https://t.co/T6MgHpY0NR
#HCC #Radioembolization #Y90
TARE Therapy (Y-90 Radioembolization): Precision Treatment for Liver Cancer
TARE delivers targeted radiation directly to liver tumors through their blood supply maximising benefits.
#TARE #Y90 #Radioembolization #LiverCancer #HCC #InterventionalRadiology #CancerCare
☢️ Radioembolization Is Redefining HCC Treatment
From bridge-to-transplant strategies to combination therapies, radioembolization continues to expand its role in the management of hepatocellular carcinoma
🔗 https://t.co/T6MgHpY0NR
#HCC #Radioembolization #Y90 #LiverCancer
If you're attending the GEST 2026 Annual Meeting, our booth is a must-stop. Come discover how Eye90 microspheres® are advancing the radioembolization landscape.
Secure your pass and add us to your must-visit list!
#GEST2026 #Radioembolization #InterventionalRadiology #EYE90
Any Day Dosing is here! ✔️ First cases with #AnyDayDosing powered by #TheraSphere360 are now underway, supporting more efficient care for patients. Thank you to the pioneering hospitals leading the way in #radioembolization and #Y90.
Liver hypertrophy post-Yttrium-90 versus portal vein embolization: A systematic review and meta-analysis
🌷https://t.co/WN8piYhDTV
Ann Hepatobiliary Pancreat Surg 2026;30(1). Sehar Salim Virani
#PortalVein #Radioembolization #therapeutic #Yttrium #Liver #Hypertrophy
☢️ Radioembolization for #HepatocellularCarcinoma
This review summarizes updated strategies and evolving clinical applications of #radioembolization in HCC, highlighting recent #guideline updates and its expanding role in locoregional therapy.
🔗 [https://t.co/untMBsZSrg]
![HepatomaRes's tweet photo. ☢️ Radioembolization for #HepatocellularCarcinoma
This review summarizes updated strategies and evolving clinical applications of #radioembolization in HCC, highlighting recent #guideline updates and its expanding role in locoregional therapy.
🔗 [https://t.co/untMBsZSrg] https://t.co/AVZc8SKdSC](https://pbs.twimg.com/media/HAW1f5tacAAMGUd.jpg)
![HepatomaRes's tweet photo. ☢️ Radioembolization for #HepatocellularCarcinoma
This review summarizes updated strategies and evolving clinical applications of #radioembolization in HCC, highlighting recent #guideline updates and its expanding role in locoregional therapy.
🔗 [https://t.co/untMBsZSrg] https://t.co/AVZc8SKdSC](https://pbs.twimg.com/media/HAW1ewAaYAAL-Ma.jpg)
![HepatomaRes's tweet photo. ☢️ Radioembolization for #HepatocellularCarcinoma
This review summarizes updated strategies and evolving clinical applications of #radioembolization in HCC, highlighting recent #guideline updates and its expanding role in locoregional therapy.
🔗 [https://t.co/untMBsZSrg] https://t.co/AVZc8SKdSC](https://pbs.twimg.com/media/HAW1dnxacAAqWth.jpg)
![HepatomaRes's tweet photo. ☢️ Radioembolization for #HepatocellularCarcinoma
This review summarizes updated strategies and evolving clinical applications of #radioembolization in HCC, highlighting recent #guideline updates and its expanding role in locoregional therapy.
🔗 [https://t.co/untMBsZSrg] https://t.co/AVZc8SKdSC](https://pbs.twimg.com/media/HAW1c0baYAAvmGO.png)
🔁 Treatment sequencing challenges
🎯 Rationale for combination strategies
💡 Implications for curative-intent therapy
#LiverCancer #Immunotherapy #Y90 #Radioembolization
@Wang_Yu_Hung @dr_yakupergun @FCademartiri @DaisukeKotani @tom_marjot @drkeithsiau @gnioannou @yreddyhf
💉 Sequencing Immunotherapy and Y-90 in #HepatocellularCarcinoma
👏 This review examines how immune checkpoint inhibitors and #Y-90 radioembolization can be optimally sequenced or combined in HCC management.
🔗 [https://t.co/HVCOaqgOon]
![HepatomaRes's tweet photo. 💉 Sequencing Immunotherapy and Y-90 in #HepatocellularCarcinoma
👏 This review examines how immune checkpoint inhibitors and #Y-90 radioembolization can be optimally sequenced or combined in HCC management.
🔗 [https://t.co/HVCOaqgOon] https://t.co/h5Ndr3aubT](https://pbs.twimg.com/media/G-qr7Q4bQAI2Ei7.jpg)
![HepatomaRes's tweet photo. 💉 Sequencing Immunotherapy and Y-90 in #HepatocellularCarcinoma
👏 This review examines how immune checkpoint inhibitors and #Y-90 radioembolization can be optimally sequenced or combined in HCC management.
🔗 [https://t.co/HVCOaqgOon] https://t.co/h5Ndr3aubT](https://pbs.twimg.com/media/G-qr6UDaYAAxZ6B.jpg)
![HepatomaRes's tweet photo. 💉 Sequencing Immunotherapy and Y-90 in #HepatocellularCarcinoma
👏 This review examines how immune checkpoint inhibitors and #Y-90 radioembolization can be optimally sequenced or combined in HCC management.
🔗 [https://t.co/HVCOaqgOon] https://t.co/h5Ndr3aubT](https://pbs.twimg.com/media/G-qr5fQa8AA4wf2.png)
Free webinar: Eight years of real-world evidence on TARE
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: https://t.co/8ODajoCS9f
✔️ Access the webinar: https://t.co/frmc5MmDTR
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
Make sure to register for the upcoming webinar: Eight years of real-world evidence on TARE
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: https://t.co/8ODajoCkjH
✔️ Registration: https://t.co/frmc5Mm64j
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
🧩 Immune Checkpoint Inhibitors & #Y-90 in #HCC
🔑 Synergy between #ICIs & Y-90
⚖️ Challenges in treatment sequencing
🎯 Future strategies to optimize outcomes
📄 Read here: [https://t.co/pJ2UY11R77]
#LiverCancer #Immunotherapy #Radioembolization #OncologyResearch
![HepatomaRes's tweet photo. 🧩 Immune Checkpoint Inhibitors & #Y-90 in #HCC
🔑 Synergy between #ICIs & Y-90
⚖️ Challenges in treatment sequencing
🎯 Future strategies to optimize outcomes
📄 Read here: [https://t.co/pJ2UY11R77]
#LiverCancer #Immunotherapy #Radioembolization #OncologyResearch https://t.co/OuxfTUTDmB](https://pbs.twimg.com/media/G02xU93awAA-6SB.jpg)
![HepatomaRes's tweet photo. 🧩 Immune Checkpoint Inhibitors & #Y-90 in #HCC
🔑 Synergy between #ICIs & Y-90
⚖️ Challenges in treatment sequencing
🎯 Future strategies to optimize outcomes
📄 Read here: [https://t.co/pJ2UY11R77]
#LiverCancer #Immunotherapy #Radioembolization #OncologyResearch https://t.co/OuxfTUTDmB](https://pbs.twimg.com/media/G02xU92acAA89cj.jpg)
![HepatomaRes's tweet photo. 🧩 Immune Checkpoint Inhibitors & #Y-90 in #HCC
🔑 Synergy between #ICIs & Y-90
⚖️ Challenges in treatment sequencing
🎯 Future strategies to optimize outcomes
📄 Read here: [https://t.co/pJ2UY11R77]
#LiverCancer #Immunotherapy #Radioembolization #OncologyResearch https://t.co/OuxfTUTDmB](https://pbs.twimg.com/media/G02xTkRaIAASckp.png)
🙌 Enjoy reading this feature paper
"Clinical Results of Holmium-166 #Radioembolization with Personalized Dosimetry for the Treatment of #Hepatocellular_Carcinoma"
🏫University Hospital Jena
🍄 Views 2124, Citations 4
Don't miss out!
🔗 https://t.co/1WzJCGuNda
#mdpijpm #HCC
Increased Voxel-Based Y90 #Radioembolization Dose to #Hepatocellular #Carcinoma Improves Imaging Response
https://t.co/oxlMzpAsLr
✍️#ICIs +#Y90 for Liver Cancer
📄“The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of #treatment sequence”
🧐Must read!
🔗https://t.co/pJ2UY11R77
#immunotherapy #radioembolization #HCC
Just read an incredible article! 📚
Title: Clinical Results of Transarterial #Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary #Liver Cancer 🦥
Online Link:🎗
https://t.co/zUWreimavg
#ET2025 will cover transarterial #radioembolization in a special topic session as well as two deep-dive sessions, allowing for close interaction and knowledge exchange with the presenting experts.
➡️ Programme: https://t.co/jehh4IAi7s
➡️ Register: https://t.co/zlxgv81e5h
In Press: Efficacy of Yttrium90 Transarterial #Radioembolization as a Bridge to Surgery in #HepatocellularCarcinoma
https://t.co/UYscsWvckL
@FlavioRochaMD
@DrMikeCavnar
@HalletJulie
@SKMaithel
@JulietOkoroh
@TheNotoriousHPB
@AradhyaNigamMD
Read now in CVIR 📖
#Radioembolization as a Spearhead Treatment of #HepatocellularCarcinoma with Localized Portal Vein #TumorThrombosis (RESOLVE): Protocol for an Open-label, Multi-center, Single-arm Trial
https://t.co/lSNrUxHCYE
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers